跳至主要内容
临床试验/NCT05511311
NCT05511311Unknown不适用

Development of Frailty Prevention Clinic in Geriatric Comprehensive Clinic RSCM: The Role of Resistance Training as Sarcopenia and Frailty Management Towards Frailty Score, Sarcopenia Score, and Quality of Life

Indonesia University2 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
220
试验地点
2
主要终点
Frailty Status

研究概览

简要总结

There is an increasing number of elderly population, not only in Indonesia, but also in the world. With increasing of age, there is also an increasing number of elderly with sarcopenia and frailty. Both of the diseases can lead to dependency, decrease quality of life, and morbidity. Besides nutrition, physical activity, especially resistance training is proven to be beneficial in improving sarcopenia and frailty condition.

Currently in Cipto Mangunkusumo National Hospital (RSCM), there is no comprehensive frailty prevention clinic in the geriatric inpatient clinics. This research can be the base of frailty and sarcopenia treatment in RSCM.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients 60 years old or orlder
  • Categorized as Pre-frail or Frail based on FRAIL criteria
  • Is not in routine physical activity in the past 3 months
  • Succeeded Mini Physical Performance Test with score 11 or more

排除标准

  • Cognitive Disturbance (Abbreviated Mental Test < 8)
  • Not consenting to join the trial

结局指标

主要结局

Frailty Status

时间窗: 12 weeks

The FRAIL scale includes 5 components: Fatigue, Resistance, Ambulation, Illness, and Loss of weight (10). Frail scale scores range from 0-5 (i.e., 1 point for each component; 0=best to 5=worst) and represent frail (3-5), pre-frail (1-2), and robust (0) health status

Sarcopenia Status

时间窗: 12 weeks

Measured using: * BIA: \<7.0 kg/m2 in men and \<5.7 kg/m2 in women * Five times sit to stand: ≥12 seconds * Hand-grip strength: \<28 kg for men and \<18 kg for women

Walking Speed

时间窗: 12 weeks

\<1.0 m/s

Patient's Quality of Life

时间窗: 12 weeks

Measured by EQ-5D: ranging from 0 ('worst imaginable health') to 100 ('best imaginable health')

次要结局

  • Prevalence of Frailty(12 weeks)
  • Prevalence of Sarcopenia(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Siti Setiati

Prof

Indonesia University

研究点 (2)

Loading locations...

相似试验

Development of Frailty Prevention Clinic in... | 临床试验